Mackall; Crystal

Patent Applications and Registrations

Patent applications and USPTO patent grants for Mackall; Crystal.The latest application filed is for "chimeric antigen receptors containing glypican 2 binding domains".

Company Profile

3.5.13

Mackall; Crystal - Stanford CA
MACKALL; Crystal - Redwood City CA
MACKALL; Crystal - Bethesda MD
Mackall; Crystal - Silver Spring MD

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Compositions and methods for treatment of cancers harboring an H3K27M mutation Grant 11,433,098 - Monje-Deisseroth , et al. September 6, 2	2022-09-06
Chimeric Antigen Receptors Containing Glypican 2 Binding Domains App 20220257653 - BOSSE; Kristopher ; et al.	2022-08-18
Compositions and methods for inhibiting T cell exhaustion Grant 11,400,117 - Mackall , et al. August 2, 2	2022-08-02
Compositions And Methods Of Expansion Of T Cell Populations App 20220186184 - Good; Zinaida ; et al.	2022-06-16
Therapeutic Antigen Binding Proteins Specific For Cd93 And Methods Of Use Thereof App 20220133794 - Majeti; Ravindra ; et al.	2022-05-05
Regulatable Cell Surface Receptors And Related Compositions And Methods App 20220041686 - Mackall; Crystal ; et al.	2022-02-10
Compositions And Methods For Modulating T Cell Exhaustion App 20210393628 - Mackall; Crystal ; et al.	2021-12-23
Chimeric Antigen Receptor Polypeptides and Methods of Using Same App 20210171602 - Mackall; Crystal ; et al.	2021-06-10
Compositions And Methods For Treatment Of Cancers Harboring An H3k27m Mutation App 20210137979 - Monje-Deisseroth; Michelle ; et al.	2021-05-13
Methods Of Treating T Cell Exhaustion By Inhibiting Or Modulating T Cell Receptor Signaling App 20210032363 - LYNN; Rachel ; et al.	2021-02-04
Methods Of Treating T Cell Exhaustion By Inhibiting Or Modulating T Cell Receptor Signaling App 20200101108 - LYNN; Rachel ; et al.	2020-04-02
Compositions And Methods For Inhibiting T Cell Exhaustion App 20190183932 - Mackall; Crystal ; et al.	2019-06-20
Alk Antibodies, Conjugates, And Chimeric Antigen Receptors, And Their Use App 20160280798 - ORENTAS; Rimas ; et al.	2016-09-29
Immunogenic peptides and methods of use for treating and preventing cancer Grant 8,614,304 - Berzofsky , et al. December 24, 2	2013-12-24
Immunogenic Peptides And Methods Of Use For Treating And Preventing Cancer App 20110081352 - Berzofsky; Jay A. ; et al.	2011-04-07
Immunogenic peptides and methods of use for treating and preventing cancer Grant 7,867,977 - Berzofsky , et al. January 11, 2	2011-01-11
Immunogenic Peptides And Methods Of Use For Treating And Preventing Cancer App 20090117116 - Berzofsky; Jay A. ; et al.	2009-05-07

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.